Published in Int J Cancer on July 29, 1998
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia (2006) 5.64
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science (1997) 4.58
Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer (1997) 3.41
Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs. Talanta (1996) 2.74
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J (2000) 2.41
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood (1999) 2.30
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood (1999) 2.28
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ (2002) 2.14
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am J Physiol Cell Physiol (2005) 1.91
Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood (1999) 1.84
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol (2006) 1.71
Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc (2009) 1.69
Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. Int Immunol (1999) 1.60
Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest (2003) 1.60
TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer (1998) 1.58
Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy (2001) 1.53
Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res (1990) 1.45
Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec (2001) 1.43
Erythropoietin as an angiogenic factor. Eur J Clin Invest (2003) 1.43
The history of the angiogenic switch concept. Leukemia (2006) 1.40
Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. Cancer Res (1983) 1.39
Angiogenesis in rheumatoid arthritis. Histol Histopathol (2006) 1.39
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene (2006) 1.31
Nuclear magnetic resonance as a tool for determining protonation constants of natural polyprotic bases in solution. Anal Biochem (1995) 1.30
Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst (1982) 1.29
Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br J Cancer (1980) 1.29
Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB-ALL. Eur J Immunol (1986) 1.22
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res (1987) 1.22
Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell Dev Biol Anim (2000) 1.22
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol (2004) 1.22
Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy (2004) 1.21
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol (1996) 1.21
The role of the vascular phase in solid tumor growth: a historical review. Neoplasia (1999) 1.20
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene (2007) 1.18
The role of mast cells in tumour angiogenesis. Br J Haematol (2001) 1.18
Bortezomib as an antitumor agent. Curr Pharm Biotechnol (2006) 1.17
New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J Vasc Res (1998) 1.16
Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol (1992) 1.15
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia (2012) 1.12
The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol (2000) 1.12
Gangliosides promote the angiogenic response. Lab Invest (1989) 1.11
Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases. Surg Endosc (2010) 1.10
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer (1999) 1.10
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ (1999) 1.09
Stephen Paget and the 'seed and soil' theory of metastatic dissemination. Clin Exp Med (2006) 1.09
Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol (1996) 1.09
Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms. Cancer Res (1991) 1.08
Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol (1996) 1.07
Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma. Histopathology (2007) 1.06
Portsmouth operative delivery trial: a comparison vacuum extraction and forceps delivery. Br J Obstet Gynaecol (1983) 1.06
First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc (2011) 1.06
Macrophages and tumor angiogenesis. Leukemia (2007) 1.04
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol (2007) 1.04
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer (1999) 1.04
In vivo (31)P-MRS assessment of cytosolic [Mg(2+)] in the human skeletal muscle in different metabolic conditions. Magn Reson Imaging (2000) 1.04
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol (2001) 1.04
Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model. Int J Cancer (1988) 1.03
Macrophages in rheumatoid arthritis. Histol Histopathol (2007) 1.02
The discovery of angiogenic factors: a historical review. Gen Pharmacol (2000) 1.01
CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells. J Immunol (2001) 1.01
Postnatal vasculogenesis. Mech Dev (2001) 1.00
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas. Neurology (2006) 1.00
Angiogenesis in asthma. Clin Exp Allergy (2009) 1.00
Erythropoietin as an angiogenic factor in gastric carcinoma. Histopathology (2003) 1.00
Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EmuMyc lymphomagenesis: a tumor suppressor role for Prep1. Mol Oncol (2010) 1.00
Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer (2000) 1.00
Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res (1987) 0.99
Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma. Leuk Lymphoma (1999) 0.99
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol (1991) 0.99
Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma. J Immunol (1986) 0.99
Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant (2006) 0.99
Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma. Ann Hematol (2009) 0.99
A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation. Cell Mol Neurobiol (1992) 0.98
Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity. Leukemia (2011) 0.98
Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int J Mol Med (2001) 0.98
Unrelated donor stem cell transplantation in adult patients with thalassemia. Bone Marrow Transplant (2005) 0.97
Maculopapular rash due to fluconazole. Clin Exp Dermatol (2008) 0.97
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res (1998) 0.97
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. J Vasc Res (2001) 0.97
Human microvascular endothelial cells from different fetal organs demonstrate organ-specific CAM expression. Exp Cell Res (2005) 0.96
Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations. Br J Pharmacol (2014) 0.96
Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol (2001) 0.96
Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer (2003) 0.95
Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia (2003) 0.95
Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum Dis (2003) 0.94
Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone Marrow Transplant (1993) 0.93
In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. J Cell Sci (1999) 0.93
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res (1986) 0.93
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia. Genes Immun (2008) 0.93
Order and disorder in the vascular network. Leukemia (2004) 0.93
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects. J Natl Cancer Inst (2000) 0.93
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma. Life Sci (2001) 0.92
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis. Clin Exp Rheumatol (2010) 0.92